Trial Profile
Solifenacin in the Treatment of Urgency Symptoms of Overactive Bladder in a Rising Dose, Randomized, Placebo-Controlled, Double-Blind Trial
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 29 Aug 2016
Price :
$35
*
At a glance
- Drugs Solifenacin (Primary)
- Indications Overactive bladder
- Focus Registrational; Therapeutic Use
- Acronyms SUNRISE
- Sponsors Astellas Pharma
- 09 Dec 2008 New trial record.